Objectives The treat-to-target (T2T) concept has been applied successfully in several inflammatory rheumatic diseases. Gout is a chronic disease with a high burden of pain and inflammation. Because the pathogenesis of gout is strongly related to…

In order to reap the benefits of lowering uric acid, such as renal protection, cardiovascular risk reduction, and possibly osteoporotic fracture prevention, one needs to treat Gout to target, and to maintain it lifelong.
So what is the target?

 Image result for uric acid picture

Arthritis Care & Research Explore this journal > Explore this journal > Previous article in issue: Continuous Improvement of Physical Functioning in Ankylosing Spondylitis Patients by Tumor Necrosis Factor Inhibitors: Three-Year Followup and Predictors Previous article in issue: Continuous Improveme…

Just because every respectable rheumatic disease with a treat-to-target strategy has a disease activity score based on quantifiable outcome measures, it doesn’t mean Gout must have GAS (Gout Activity Score)!